Purpose: Commissioning of a linear accelerator is a process of acquiring a set of data used for patient treatment. This article presents the beam data measurement results from the commissioning of a VitalBeamTM linac. Materials and Methods: Dosimetric properties for 6,10, and 15 MV photon beams and 6, 9, 12, and 16 MeV electron beams have been performed. Parameters, including Percentage Depth Dose (PDD), depth dose profile, symmetry, flatness, quality index, output factors, and the vital data for Treatment Planning System (TPS) commissioning were measured. The imported data were checked by CIRS phantom accordingly to IAEA TRS-430, TECDOC. Eight different positions of CIRS phantom CT were planned and treated. Finally, the calculated dose at a determined position was compared with measuring data to TPS validation. Results: After comparing 84 points in a different plan, the 83 points were in agreement with the criteria, and just for one point in 15 MV failed. Conclusion: Commissioning of dose and field flatness and symmetry are in tolerance intervals given by Varian. This proves that the studied lines meet the specification and can be used in clinical practice with all available electron and photon energies.

Purpose: Radiation Therapy has a fundamental role in the treatment of cancer. Achieving Tumor Control Probability (TCP), while avoiding normal tissue complication is the goal of this treatment modality. The sensitivity of the thyroid gland to radiation increases the risk of developing secondary thyroid cancer and hypothyroidism. Materials and Methods: The average dose to the thyroid from head and neck irradiation was measured using in vivo dosimetry (Thermolumincsence Dosimetry). The Radiotherapy technique was given using 6 MV x-rays from an Elekta compact linear accelerator and conformal technique delivered 1.8 to 2.0 Gy over 5 sequential days per week. Results: The average absorbed dose to the thyroid from head and neck radiotherapy was 4.4% of the prescription dose and from whole brain radiotherapy was 0.7% of the prescription dose. Thyroid Stimulating Hormone (TSH) levels were determined in 30 patients before and after completion of radiation therapy. The average concentration of TSH increased from 0.88 +/- 0.55 (pre-radiotherapy) to 1.7 +/- 0.66 (post-radiotherapy), (p < 0.05). Conclusion: Thyroid absorbed dose was less than the threshold dose for patients who received radiotherapy to the head and neck based on thyroid function tests